Clinical Trials
All Clinical Trials - Page 21 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04901104N/ANot Yet Recruiting
Long-term Prognosis of Patients With Sepsis After Immunotherapy
Thymosin-Alpha-1
- NCT05073692N/ACompleted
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Liraglutide
- NCT04781998Phase 4Completed
Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
Liraglutide
- NCT04615910Phase 2Unknown
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
Exenatide
- NCT04964934Phase 3Active Not Recruiting
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
Gonadorelin
- NCT04941521Phase 1/Phase 2Completed
Exenatide for Treating Cocaine Use Disorder
Exenatide
- NCT04883346Phase 2Completed
Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
Liraglutide
- NCT04916470Phase 3Completed
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
Semaglutide
- NCT04903509Phase 1Completed
A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
Liraglutide
- NCT04904913Phase 2Completed
A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
Mazdutide
- NCT04962503Phase 2Completed
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
Afamelanotide
- NCT04952779N/ACompleted
Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Liraglutide
- NCT04748042Phase 2Active Not Recruiting
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
Gonadorelin
- NCT04934722Phase 3Completed
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension
Gonadorelin
- NCT04823208Phase 1Completed
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
Retatrutide
- NCT04881760Phase 2Completed
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
Retatrutide
- NCT04657679Phase 4Terminated
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
Gonadorelin
- NCT04865744Phase 4Completed
The Effect of Semaglutide on Pituitary Function
Semaglutide
- NCT04777409Phase 3Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Semaglutide
- NCT04777396Phase 3Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Semaglutide
- NCT04404335N/ACompleted
The Role of Anti-inflammatory Cytokines and Antimicrobial Peptide LL-37 Biomarkers in the Treatment of Periodontal Disease.
Ll-37
- NCT04876027Phase 4Completed
GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
Dulaglutide
- NCT04867785Phase 2Completed
A Study of LY3437943 in Participants With Type 2 Diabetes
Retatrutide
- NCT04844918Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
Tirzepatide
- NCT04943068Phase 3Completed
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
PT-141
- NCT04687514Phase 2Completed
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
Dulaglutide
- NCT04734730Phase 2Recruiting
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Gonadorelin
- NCT05005741Phase 4Unknown
The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
Dulaglutide
- NCT04736108Phase 2Unknown
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
Gonadorelin
- NCT04878393N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
Semaglutide
- NCT04738799N/ACompleted
The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring
Ghrp-6
- NCT04909333N/ACompleted
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Exenatide
- NCT04771273Phase 2Completed
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
Survodutide
- NCT04847557Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Tirzepatide
- NCT04809220Phase 3Completed
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Dulaglutide
- NCT04822181Phase 3Active Not Recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Semaglutide
- NCT05086614Phase 3Recruiting
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
Thymosin-Alpha-1
- NCT06867250N/ACompleted
Peri-implant Vitamin D and Cathelicidin (LL-37) Levels
Ll-37
- NCT04597411Phase 1Active Not Recruiting
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
Gonadorelin
- NCT05360537Phase 4Completed
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
Liraglutide
- NCT04657016Phase 3Completed
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
Tirzepatide
- NCT04657003Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
Tirzepatide
- NCT04660643Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
Tirzepatide
- NCT04680767Phase 1Completed
A Study of LY3502970 in Healthy Male Participants
Orforglipron
- NCT04639414Phase 4Active Not Recruiting
Combined Active Treatment in Type 2 Diabetes with NASH
Semaglutide
- NCT04702516Phase 1/Phase 2Unknown
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
Semaglutide
- NCT04683237Phase 2/Phase 3Withdrawn
Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
Liraglutide
- NCT04788511Phase 3Completed
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
Semaglutide
- NCT04783636Phase 1Unknown
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
Gonadorelin
- NCT04667377Phase 2Completed
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
Survodutide